Topics
Glioblastoma | Prognosis | Magnetic Resonance Imaging
Home > Publications > Topics > Glioblastoma > Prognosis > Magnetic Resonance Imaging
Chida D, Okita Y, Utsugi R, Kuroda H, Hirayama R, Kijima N,
Arisawa A, Kagawa N, Kanemura Y, Yoshimura S, Tomiyama N, Kishima
H.
Dynamic susceptibility
contrast‑enhanced perfusion magnetic resonance imaging
parameters for predicting MGMT
promoter methylation and prognostic value in newly diagnosed
patients with glioblastoma.
Oncol
Lett. 2024 Oct 14;28(6):610. doi:
10.3892/ol.2024.14741. PMID:
39493435. Observational study. ˍ
Cozzi FM, Mayrand RC, Wan Y, Price SJ.
Predicting
glioblastoma progression using MR diffusion tensor imaging: A
systematic review.
J
Neuroimaging. 2024 Dec 9;35(1):e13251. doi:
10.1111/jon.13251. PMID:
39648937. Review. ˍ
Cerebral blood volume (CBV) measurements
Henriksen OM, Muhic A, Lundemann MJ, Larsson HBW, Lindberg U,
Andersen TL, Hasselbalch B, Møller S, Marner L, Madsen K,
Larsen VA, Poulsen HS, Hansen AE, Law I.
Added
prognostic value of DCE blood volume imaging in patients with
suspected recurrent or residual glioblastoma-A hybrid [18F]FET
PET/MRI study.
Neurooncol
Adv. 2024 Nov 18;6(1):vdae196. doi:
10.1093/noajnl/vdae196. PMID:
39664680. Observational study. ˍ